Equities researchers at Craig Hallum began coverage on shares of Teladoc Inc. (NYSE:TDOC) in a research report issued on Monday. The firm set a “buy” rating and a $24.00 price target on the stock. Craig Hallum’s price target indicates a potential upside of 32.60% from the company’s current price.

TDOC has been the topic of a number of other research reports. FBR & Co reiterated a “buy” rating on shares of Teladoc in a research note on Sunday, August 28th. Zacks Investment Research downgraded shares of Teladoc from a “hold” rating to a “sell” rating in a report on Tuesday, September 20th. Chardan Capital began coverage on shares of Teladoc in a report on Wednesday, November 16th. They set a “buy” rating and a $24.00 price target on the stock. Piper Jaffray Cos. reissued an “overweight” rating and set a $21.00 price target (down from $22.00) on shares of Teladoc in a report on Friday, August 5th. Finally, Oppenheimer Holdings Inc. reissued an “outperform” rating and set a $24.00 price target (down from $25.00) on shares of Teladoc in a report on Friday, August 5th. One research analyst has rated the stock with a sell rating, one has issued a hold rating and eleven have assigned a buy rating to the company’s stock. Teladoc presently has a consensus rating of “Buy” and an average price target of $23.00.

Analyst Recommendations for Teladoc (NYSE:TDOC)

Shares of Teladoc (NYSE:TDOC) opened at 18.10 on Monday. The stock has a 50 day moving average of $16.73 and a 200-day moving average of $15.97. Teladoc has a 12-month low of $9.08 and a 12-month high of $22.00. The company’s market capitalization is $833.18 million.

Teladoc (NYSE:TDOC) last released its quarterly earnings data on Thursday, October 27th. The company reported ($0.33) earnings per share for the quarter, topping the Zacks’ consensus estimate of ($0.36) by $0.03. The firm had revenue of $32.40 million for the quarter, compared to analyst estimates of $32.29 million. Teladoc had a negative net margin of 69.15% and a negative return on equity of 32.68%. The business’s quarterly revenue was up 62.0% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.35) earnings per share. Equities research analysts forecast that Teladoc will post ($1.42) EPS for the current year.

TRADEMARK VIOLATION WARNING: “Craig Hallum Initiates Coverage on Teladoc Inc. (TDOC)” was first posted by Financial Market News and is owned by of Financial Market News. If you are accessing this article on another site, it was illegally stolen and republished in violation of U.S. & international trademark & copyright legislation. The correct version of this article can be accessed at http://www.financial-market-news.com/craig-hallum-initiates-coverage-on-teladoc-inc-tdoc/1209676/.

In other Teladoc news, VP Mark Hirschhorn sold 5,000 shares of Teladoc stock in a transaction dated Thursday, November 10th. The shares were sold at an average price of $17.50, for a total transaction of $87,500.00. Following the completion of the sale, the vice president now directly owns 267,687 shares in the company, valued at $4,684,522.50. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 5.94% of the company’s stock.

Several large investors have recently made changes to their positions in TDOC. California State Teachers Retirement System boosted its stake in shares of Teladoc by 116.8% in the second quarter. California State Teachers Retirement System now owns 43,509 shares of the company’s stock worth $697,000 after buying an additional 23,438 shares in the last quarter. Schwab Charles Investment Management Inc. raised its position in Teladoc by 100.2% in the second quarter. Schwab Charles Investment Management Inc. now owns 42,830 shares of the company’s stock valued at $687,000 after buying an additional 21,436 shares during the last quarter. CWM LLC raised its position in Teladoc by 171.7% in the second quarter. CWM LLC now owns 371,358 shares of the company’s stock valued at $5,949,000 after buying an additional 234,678 shares during the last quarter. BlackRock Advisors LLC raised its position in Teladoc by 3.1% in the second quarter. BlackRock Advisors LLC now owns 445,970 shares of the company’s stock valued at $7,145,000 after buying an additional 13,546 shares during the last quarter. Finally, Bank of New York Mellon Corp raised its position in Teladoc by 55.9% in the second quarter. Bank of New York Mellon Corp now owns 64,138 shares of the company’s stock valued at $1,027,000 after buying an additional 22,997 shares during the last quarter. Institutional investors and hedge funds own 53.34% of the company’s stock.

About Teladoc

Teladoc, Inc, together with its subsidiaries, is a telehealth company. The Company offers telehealth platform, delivering on-demand healthcare anytime, anywhere, through mobile devices, the Internet, video and phone. The Company operates through health services segment. Its solution connects its Members, with its over 3,000 board-certified physicians and behavioral health professionals who treat a range of conditions and cases from acute diagnoses, such as upper respiratory infection, urinary tract infection and sinusitis to dermatological conditions, anxiety and smoking cessation.

5 Day Chart for NYSE:TDOC

Receive News & Ratings for Teladoc Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Inc. and related companies with MarketBeat.com's FREE daily email newsletter.